一種新型超聲波血管內系統被設計用于治療血栓合成透析移植（thrombosed synthetic dialysis access grafts）。這種系統已經獲得了美國食品藥品管理局的許可。

Resolution血管內系統是由OmniSonics醫療技術公司(Wilmington, MA, USA)制造的，是一種便攜式系統，由兩種主要成分組成，發生器和Resolution系統工具何。該工具盒有貼附導線的手工配件和附屬的沖洗導管。這種手工配件將來自發生器的電子信號轉換為低能量的超聲能量，在整個長度的小直徑治療導線內360o發射，產生氣穴流體作用，從而破碎血栓中的纖維基質，而且不會破壞周圍結構。

該設備正在接受治療外周血管(深靜脈血栓、外周四肢缺血和導管清除)堵塞、神經血管和冠狀動脈疾病的評估。

Treatment for Thrombosed Dialysis Grafts
 
A new ultrasonic endovascular system is designed for use in the treatment of thrombosed synthetic dialysis access grafts. The system has been cleared by the U.S. Food and Drug Administration (FDA).

The Resolution endovascular system, made by OmniSonics Medical Technologies (Wilmington, MA, USA), is a portable system that consists of two primary components, the generator and the Resolution system kit. The kit consists of a hand-piece with an attached wire and accessory irrigation tubing. This hand-piece converts the electronic signal from the generator to low-power ultrasonic energy transmitted 360o along the entire length of a small-diameter therapeutic wire, generating a cavitational streaming effect that breaks the fibrin matrix found in the thrombus without damaging surrounding structures.

The device is currently being evaluated for use in the treatment of peripheral occlusive conditions (deep vein thrombosis, peripheral limb ischemia, and catheter clearance), as well as neurovascular and coronary applications.